Enhanced primary and recall CD8+ T cell responses like increased cell number, granule mobilization, and IFN-γ production were observed upon GITR activation during immunization with melanoma differentiation antigens, and these effects were only partially dependent on CD4+ T cells. The gene discussed is TNFRSF18; the disease is melanoma.